A detailed history of Fred Alger Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Fred Alger Management, LLC holds 102,765 shares of ABBV stock, worth $18.5 Million. This represents 0.1% of its overall portfolio holdings.

Number of Shares
102,765
Previous 87,433 17.54%
Holding current value
$18.5 Million
Previous $15 Million 35.33%
% of portfolio
0.1%
Previous 0.07%

Shares

28 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$163.84 - $199.33 $2.51 Million - $3.06 Million
15,332 Added 17.54%
102,765 $20.3 Million
Q2 2024

Aug 14, 2024

SELL
$154.79 - $180.76 $4.28 Million - $5 Million
-27,662 Reduced 24.03%
87,433 $15 Million
Q1 2024

May 15, 2024

BUY
$159.82 - $182.1 $8.22 Million - $9.36 Million
51,407 Added 80.72%
115,095 $21 Million
Q4 2023

Feb 14, 2024

SELL
$137.6 - $154.97 $4.79 Million - $5.4 Million
-34,845 Reduced 35.36%
63,688 $9.87 Million
Q3 2023

Nov 14, 2023

SELL
$133.59 - $154.65 $11.3 Million - $13.1 Million
-84,443 Reduced 46.15%
98,533 $14.7 Million
Q2 2023

Aug 14, 2023

SELL
$132.51 - $164.9 $101 Million - $126 Million
-765,484 Reduced 80.71%
182,976 $24.7 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $105 Million - $121 Million
-727,003 Reduced 43.39%
948,460 $151 Million
Q4 2022

Feb 14, 2023

BUY
$138.31 - $165.87 $22.9 Million - $27.4 Million
165,489 Added 10.96%
1,675,463 $271 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $30.9 Million - $35.4 Million
229,925 Added 17.96%
1,509,974 $203 Million
Q2 2022

Aug 15, 2022

SELL
$137.62 - $174.96 $38.1 Million - $48.5 Million
-276,992 Reduced 17.79%
1,280,049 $196 Million
Q1 2022

May 16, 2022

SELL
$131.98 - $163.75 $31.7 Million - $39.4 Million
-240,564 Reduced 13.38%
1,557,041 $252 Million
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $190 Million - $240 Million
1,766,693 Added 5715.23%
1,797,605 $243 Million
Q3 2021

Nov 15, 2021

SELL
$106.4 - $120.78 $9.49 Million - $10.8 Million
-89,167 Reduced 74.26%
30,912 $3.33 Million
Q2 2021

Aug 16, 2021

SELL
$105.21 - $117.21 $18 Million - $20.1 Million
-171,432 Reduced 58.81%
120,079 $13.5 Million
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $47.1 Million - $51.9 Million
-460,589 Reduced 61.24%
291,511 $31.5 Million
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $53.9 Million - $72.8 Million
669,584 Added 811.46%
752,100 $80.6 Million
Q3 2020

Nov 13, 2020

SELL
$85.91 - $100.83 $7.49 Million - $8.79 Million
-87,212 Reduced 51.38%
82,516 $7.23 Million
Q2 2020

Aug 14, 2020

SELL
$73.37 - $98.18 $25.5 Million - $34.1 Million
-347,056 Reduced 67.16%
169,728 $16.7 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $42.5 Million - $64.5 Million
-659,485 Reduced 56.07%
516,784 $39.4 Million
Q4 2019

Feb 14, 2020

BUY
$72.13 - $90.25 $37.2 Million - $46.5 Million
515,272 Added 77.95%
1,176,269 $104 Million
Q3 2019

Nov 14, 2019

BUY
$62.98 - $75.72 $38.5 Million - $46.3 Million
611,751 Added 1242.23%
660,997 $50.1 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $2.28 Million - $2.91 Million
34,644 Added 237.26%
49,246 $3.58 Million
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $351,372 - $413,548
-4,555 Reduced 23.78%
14,602 $1.18 Million
Q3 2018

Nov 14, 2018

SELL
$88.91 - $98.84 $303,805 - $337,736
-3,417 Reduced 15.14%
19,157 $1.81 Million
Q2 2018

Jul 19, 2018

SELL
$89.78 - $106.23 $166 Million - $196 Million
-1,845,687 Reduced 98.79%
22,574 $2.09 Million
Q1 2018

May 10, 2018

BUY
$92.01 - $123.21 $56.9 Million - $76.2 Million
618,563 Added 49.5%
1,868,261 $177 Million
Q4 2017

Feb 14, 2018

BUY
$89.56 - $98.21 $99.2 Million - $109 Million
1,108,061 Added 782.32%
1,249,698 $121 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $9.89 Million - $12.6 Million
141,637
141,637 $12.6 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Fred Alger Management, LLC Portfolio

Follow Fred Alger Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fred Alger Management, LLC with notifications on news.